Home › Funds › Paulson & Co › MDGL
Paulson & Co position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)1.34M sh
Reported value held$719.52M
Portfolio Weight27.94%
First reportedQ2 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2023 | 350.20K | $80.90M | New |
| Q3 2023 | 500.00K | $73.02M | Add |
| Q4 2023 | 1.11M | $255.85M | Add |
| Q1 2024 | 1.77M | $474.00M | Add |
| Q2 2024 | 1.85M | $518.30M | Add |
| Q3 2024 | 2.04M | $392.61M | Add |
| Q4 2024 | 2.04M | $630.10M | Hold |
| Q1 2025 | 2.10M | $695.43M | Add |
| Q2 2025 | 2.09M | $632.37M | Hold |
| Q3 2025 | 1.91M | $874.90M | Reduce |
| Q4 2025 | 1.71M | $994.36M | Reduce |
| Q1 2026 | 1.39M | $728.77M | Reduce |
| Q2 2026 | 1.34M | $719.52M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MDGL
- Vanguard Group 1.81M sh · $1.05B · Q4 2025
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- BlackRock Inc 1.20M sh · $644.75M · Q2 2026
- Wellington Management Group 825.71K sh · $443.37M · Q2 2026
- Citadel Advisors 688.13K sh · $369.49M · Q2 2026
- UBS Group AG 401.71K sh · $215.70M · Q2 2026
- Geode Capital Management 374.88K sh · $201.34M · Q2 2026
- Fidelity Management & Research (FMR) 356.20K sh · $191.26M · Q2 2026
- Invesco Ltd 301.44K sh · $161.86M · Q2 2026
- Goldman Sachs Group 246.28K sh · $132.24M · Q2 2026
- Norges Bank Investment Management 213.89K sh · $114.85M · Q2 2026